Cargando…
Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China
The association between Toxoplasma gondii (T. gondii) infection and malignancy has attracted increased attention in recent years, but little is known of T. gondii infection among women diagnosed with a gynecological tumor (GT) in China. We conducted a case-control study involving 460 women diagnosed...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760017/ https://www.ncbi.nlm.nih.gov/pubmed/36540800 http://dx.doi.org/10.7717/peerj.14569 |
_version_ | 1784852364054757376 |
---|---|
author | Wang, Zhongjun Qu, Tingting Qi, Huiyang Zhao, Shuchao Shi, Hailei Bai, Wenye Yu, Yang Wu, Xiao Zhao, Peng |
author_facet | Wang, Zhongjun Qu, Tingting Qi, Huiyang Zhao, Shuchao Shi, Hailei Bai, Wenye Yu, Yang Wu, Xiao Zhao, Peng |
author_sort | Wang, Zhongjun |
collection | PubMed |
description | The association between Toxoplasma gondii (T. gondii) infection and malignancy has attracted increased attention in recent years, but little is known of T. gondii infection among women diagnosed with a gynecological tumor (GT) in China. We conducted a case-control study involving 460 women diagnosed with a GT and 460 age-matched healthy controls (HCs) to estimate the infection process of T. gondii and understand the risk factors of T. gondii infection in patients with a GT. Levels of anti-T. gondii IgG and IgM were measured by enzyme-linked immunoassays every 12 months. After a median follow-up time of 4.3 years (range 4 to 5 years), 55/460 (11.96%) patients with a GT and 15/460 (3.26%) HCs were seroprevalence for T. gondii antibodies, respectively (P = 0.001). IgG antibodies against T. gondii were found in 54 GT patients (11.74%) and 15 HCs (3.26%), respectively (P = 0.001). The seroprevalence of T. gondii IgM antibodies was similar in patients with a GT and with HCs (2.83% vs 1.3%, P = 0.105). Multivariate stepwise logistic regression analysis revealed contact with cats (OR, 6.67; 95% CI [2.89–10.75]; P = 0.001), exposure to soil (OR, 2.16; 95% CI [1.14–4.10]; P = 0.019), being a farm-worker (OR, 4.17; 95% CI [1.20–11.49]; P = 0.006) and history of chemotherapy (OR, 3.16; 95% CI [1.56–6.45]; P = 0.001) to be independent risk factors for T. gondii infection. Women with an ovarian cancer or endometrial cancer had higher T. gondii seroprevalence than that of HCs. Moreover, T. gondii infection in patients with a GT mostly acquired within two years of diagnosis, but the infection in healthy controls had no obvious time characteristics. Here, we demonstrated that T. gondii infection is significantly higher in patients with a GT (especially in women with an ovarian tumor) compared to HCs. Thus, infection with this parasite should be avoided in patients with a GT, and the causal relationship between T. gondii and GTs should be studied in detail. |
format | Online Article Text |
id | pubmed-9760017 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | PeerJ Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97600172022-12-19 Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China Wang, Zhongjun Qu, Tingting Qi, Huiyang Zhao, Shuchao Shi, Hailei Bai, Wenye Yu, Yang Wu, Xiao Zhao, Peng PeerJ Parasitology The association between Toxoplasma gondii (T. gondii) infection and malignancy has attracted increased attention in recent years, but little is known of T. gondii infection among women diagnosed with a gynecological tumor (GT) in China. We conducted a case-control study involving 460 women diagnosed with a GT and 460 age-matched healthy controls (HCs) to estimate the infection process of T. gondii and understand the risk factors of T. gondii infection in patients with a GT. Levels of anti-T. gondii IgG and IgM were measured by enzyme-linked immunoassays every 12 months. After a median follow-up time of 4.3 years (range 4 to 5 years), 55/460 (11.96%) patients with a GT and 15/460 (3.26%) HCs were seroprevalence for T. gondii antibodies, respectively (P = 0.001). IgG antibodies against T. gondii were found in 54 GT patients (11.74%) and 15 HCs (3.26%), respectively (P = 0.001). The seroprevalence of T. gondii IgM antibodies was similar in patients with a GT and with HCs (2.83% vs 1.3%, P = 0.105). Multivariate stepwise logistic regression analysis revealed contact with cats (OR, 6.67; 95% CI [2.89–10.75]; P = 0.001), exposure to soil (OR, 2.16; 95% CI [1.14–4.10]; P = 0.019), being a farm-worker (OR, 4.17; 95% CI [1.20–11.49]; P = 0.006) and history of chemotherapy (OR, 3.16; 95% CI [1.56–6.45]; P = 0.001) to be independent risk factors for T. gondii infection. Women with an ovarian cancer or endometrial cancer had higher T. gondii seroprevalence than that of HCs. Moreover, T. gondii infection in patients with a GT mostly acquired within two years of diagnosis, but the infection in healthy controls had no obvious time characteristics. Here, we demonstrated that T. gondii infection is significantly higher in patients with a GT (especially in women with an ovarian tumor) compared to HCs. Thus, infection with this parasite should be avoided in patients with a GT, and the causal relationship between T. gondii and GTs should be studied in detail. PeerJ Inc. 2022-12-15 /pmc/articles/PMC9760017/ /pubmed/36540800 http://dx.doi.org/10.7717/peerj.14569 Text en © 2022 Wang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
spellingShingle | Parasitology Wang, Zhongjun Qu, Tingting Qi, Huiyang Zhao, Shuchao Shi, Hailei Bai, Wenye Yu, Yang Wu, Xiao Zhao, Peng Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China |
title | Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China |
title_full | Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China |
title_fullStr | Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China |
title_full_unstemmed | Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China |
title_short | Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China |
title_sort | seroprevalence of toxoplasma gondii infection in women with a gynecological tumor living in eastern china |
topic | Parasitology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760017/ https://www.ncbi.nlm.nih.gov/pubmed/36540800 http://dx.doi.org/10.7717/peerj.14569 |
work_keys_str_mv | AT wangzhongjun seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina AT qutingting seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina AT qihuiyang seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina AT zhaoshuchao seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina AT shihailei seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina AT baiwenye seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina AT yuyang seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina AT wuxiao seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina AT zhaopeng seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina |